Comments
Peregrine soars as cancer drug meets trial goal
22.05.2012. | (Reuters) - Peregrine Pharmaceuticals Inc said results from a mid-stage trial showed that its key experimental drug performed better than standard chemotherapy in lung cancer patients who had not responded to primary therapy, sending its shares up 36 percent....
